The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate
- PMID: 20461386
- PMCID: PMC3062770
- DOI: 10.1007/s00345-010-0566-y
The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate
Abstract
Purpose: The aim of the study was to evaluate the applicability of the modified Clavien classification system (CCS) in grading perioperative complications of transurethral resection of the prostate (TURP).
Methods: All patients with benign prostatic hyperplasia submitted to monopolar TURP from January 2006 to February 2008 at a non-academic center were evaluated for complications occurring up to the end of the first postoperative month. All complications were classified according to the modified CCS independently by two urologists, and the final decision was based on consensus. If multiple complications per patient occurred, categorization was done in more than one grade. Results were presented as complication rates per grade.
Results: Forty-four complications were recorded in 31 out of 198 patients (overall perioperative morbidity rate: 15.7%), and their grading was generally easy, non-time-consuming and straightforward. Most of them were classified as grade I (59.1%) and II (29.5%). Higher grade complications were scarce (grade III: 2.3% and grade IV: 6.8%, respectively) There was one death (grade V: 2.3%) due to acute myocardial infarction (overall mortality rate: 0.5%). Negative outcomes such as mild dysuria during this early postoperative period or retrograde ejaculation were considered sequelae and were not recorded. Nobody was complicated with severe dysuria. There was one re-operation due to residual adenoma (0.5%).
Conclusions: The modified CCS represents a straightforward and easily applicable tool that may help urologists to classify the complications of TURP in a more objective and detailed way. It may serve as a standardized platform of communication among clinicians allowing for sound comparisons.
Similar articles
-
Contemporary monopolar and bipolar transurethral resection of the prostate: prospective assessment of complications using the Clavien system.Int Urol Nephrol. 2013 Aug;45(4):951-9. doi: 10.1007/s11255-013-0476-1. Epub 2013 May 31. Int Urol Nephrol. 2013. PMID: 23722819
-
Assessing the Complications of Monopolar Transurethral Resection of the Prostate (M-TURP) Using Clavien-Dindo Complications Grading System.Ethiop J Health Sci. 2022 May;32(3):605-612. doi: 10.4314/ejhs.v32i3.17. Ethiop J Health Sci. 2022. PMID: 35813687 Free PMC article.
-
Results from an international multicentre double-blind randomized controlled trial on the perioperative efficacy and safety of bipolar vs monopolar transurethral resection of the prostate.BJU Int. 2012 Jan;109(2):240-8. doi: 10.1111/j.1464-410X.2011.10222.x. Epub 2011 May 9. BJU Int. 2012. PMID: 21557796 Clinical Trial.
-
Monopolar transurethral resection of the big prostate, experience at Prince Hussein Bin Abdullah Urology Center.J Pak Med Assoc. 2011 Jul;61(7):628-31. J Pak Med Assoc. 2011. PMID: 22204233 Review.
-
Economic Value of the Transurethral Resection in Saline System for Treatment of Benign Prostatic Hyperplasia in England and Wales: Systematic Review, Meta-analysis, and Cost-Consequence Model.Eur Urol Focus. 2018 Mar;4(2):270-279. doi: 10.1016/j.euf.2016.03.002. Epub 2016 Mar 23. Eur Urol Focus. 2018. PMID: 28753756
Cited by
-
Grading complications after transurethral resection of prostate using modified Clavien classification system and predicting complications using the Charlson comorbidity index.Int Urol Nephrol. 2013 Apr;45(2):347-54. doi: 10.1007/s11255-013-0399-x. Epub 2013 Feb 16. Int Urol Nephrol. 2013. PMID: 23417169
-
Incidence and risk factors of in-hospital venous thromboembolism in non-oncological urological inpatients: A single center experience.Asian J Urol. 2023 Oct;10(4):546-554. doi: 10.1016/j.ajur.2021.11.007. Epub 2021 Nov 24. Asian J Urol. 2023. PMID: 39186456 Free PMC article.
-
Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study.Prostate Cancer Prostatic Dis. 2020 Jun;23(2):356-363. doi: 10.1038/s41391-019-0196-4. Epub 2019 Dec 11. Prostate Cancer Prostatic Dis. 2020. PMID: 31827239
-
Immediate Transurethral Plasma Kinetic Enucleation of the Prostate Gland for Treatment of Benign Prostatic Hyperplasia-Associated Massive Hemorrhage: A Single-Center Experience.Front Surg. 2022 Jan 12;8:810175. doi: 10.3389/fsurg.2021.810175. eCollection 2021. Front Surg. 2022. PMID: 35096959 Free PMC article.
-
Impact of Obesity on Clinical Presentation and Surgical Outcomes in Patients with Benign Prostate Hyperplasia Receiving Greenlight Laser Prostatectomy.Clin Interv Aging. 2024 Dec 9;19:2071-2083. doi: 10.2147/CIA.S472579. eCollection 2024. Clin Interv Aging. 2024. PMID: 39678145 Free PMC article.
References
-
- Herrmann TR, Bach T, Imkamp F, et al. Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol. 2010;28:45–51. doi: 10.1007/s00345-009-0503-0. - DOI - PubMed
-
- Lourenco T, Armstrong N, N’Dow J, et al. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technol Assess. 2008;12:1–516. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical